【摘 要】
：
The diagnostic test of ALK rearrangement in non-small-cell lung cancer (NSCLC) for crizotinib treatment is currently done on tumor biopsies or fine needle aspirations.The present study was designed to
【机 构】
：
Gustave Roussy France
论文部分内容阅读
The diagnostic test of ALK rearrangement in non-small-cell lung cancer (NSCLC) for crizotinib treatment is currently done on tumor biopsies or fine needle aspirations.The present study was designed to evaluate-1) whether ALK-rearrangement diagnosis could be performed using circulating tumor cells (CTCs),-2) whether CTCs harboring ALK-rearrangement could be monitored in ALKpositive patients treated by crizotinib.
其他文献
Background: Anal squamous cell carcinoma with lymph node metastases is associated with poor outcome.There remains a need for a better method to diagnose inguinal lymph node metastases which is minimal
How to define sensitivity and validation in next generation diagnoses?-How to concurrently achieving highest sensitivity and lowest false positivity.Can it possible using traditional PCR to enrich mul
Although mechanisms of the action have yet been well-understood, non-steroidal anti-inflammatory drugs (NSAIDs) are widely reported to display strong efficacy for cancer prevention.The most known anti
Monoclonal antibody (McAb) is the key tool for cancer immunodiagnosis and immunotherapy.In this study, a cell clone which kept secreting high-titer IgGl-type McAb named N J001 against human non-small
Many specific molecular alterations in soft tissue and blastemal tumors have been described recently.These modifications are usually specific and their detection allows an accurate tumor classificatio
Determining the in-situ immune status of diseased organs is mostly subject to visual estimation, or-at best-to manual counting.Hence, experts usually have the choice of the "least of evils" between gu
EML4-ALK fusion gene is found in only a small subset (2-6%) of non-small cell lung cancer.Using high sensitive and specific detection method to identify this rare but important fusion in patients with
There is increasing evidence that circulating tumour cell (CTC) presence in patient blood is an important indicator of poor prognosis.Thus, quantification of CTCs may advance prognosis.To quantify and
Non-invasive, accurate tests to screen for early stages ofcolorectal cancer (CRC) are not available today.The aim of this study is to further develop and validate a test that differentiates subjects w
Current investigation for patients with colorectal symptoms without overt rectal bleeding is undertaken by colonoscopy or by flexible sigrnoidoscopy and barium enema.A large majority of patients do no